Sonntag, 11. April 2021
Navigation öffnen
Anzeige:
Lonsurf
 
JOURNAL ONKOLOGIE – STUDIE

Assessing Health-related Quality of Life in Sarcoma Patients

Rekrutierend

NCT-Nummer:
NCT04071704

Studienbeginn:
Mai 2019

Letztes Update:
28.08.2019

Wirkstoff:
-

Indikation (Clinical Trials):
Sarcoma

Geschlecht:
Alle

Altersgruppe:
Erwachsene (18+)

Phase:
-

Sponsor:
The Netherlands Cancer Institute, The Netherlands Cancer Institute

Collaborator:
Radboud University, Leiden University Medical Center, MOUNT SINAI HOSPITAL, Centre Leon Berard, University Hospital Carl Gustav Carus, Heidelberg University, Johannes Gutenberg University Mainz, Hippocration General Hospital, Fondazione IRCCS Istituto Nazionale d

Studienleiter

Olga Husson, PhD
Principal Investigator
The Netherlands Cancer Institute
Winette van der Graaf, PhD, MD
Principal Investigator
The Netherlands Cancer Institute

Kontakt

Studienlocations
(3 von 7)

University Hospital Carl Gustav Carus
Dresden
(Sachsen)
GermanyRekrutierend» Google-Maps
Johannes Gutenberg University Mainz
Mainz
(Rheinland-Pfalz)
GermanyRekrutierend» Google-Maps
University of Heidelberg
Mannheim
(Baden-Württemberg)
GermanyRekrutierend» Google-Maps
Netherlands Cancer Institute
Amsterdam
NetherlandsRekrutierend» Google-Maps
Radboud University Medical Centre
Nijmegen
NetherlandsRekrutierend» Google-Maps
Alle anzeigen

Studien-Informationen

Detailed Description:

The investigators will follow the EORTC QLG questionnaire development guidelines. First, a computerized search of the academic literature will be performed to identify all relevant HRQoL issues for and existing HRQoL questionnaires currently used among patients with sarcoma. In parallel, semi-structured interviews will be conducted worldwide with patients with sarcoma(N=154) and health care professionals (HCPs; N=30; phase 1a). The patient sample will be stratified to capture diversity across the sarcoma population tumour location (extremities, axial, head and neck, thorax, retroperitoneal/intra-abdominal and gynecological), stage (localized vs. metastatic disease ) and type or lines of treatment .

This list of HRQoL issues generated by the a) literature search, b) relevant items from the Item Library, and c) semi-structured patient and HCP interviews, and will be consolidated into a comprehensive list of issues for all languages of collaborating countries.

In phase 1b, the new list of HRQoL issues will be presented to another group of patients with sarcoma(N=475) and HCPs (N=30). Patients and HCPs will be asked to rate the HRQoL issues on relevance (4point Likert scale) and to prioritize the 25 most important issues.
 

Ein-/Ausschlusskriterien

Inclusion Criteria:

- Age at diagnosis 18 years or older

- Having a confirmed diagnosis of sarcoma

Exclusion Criteria:

- Having any psychiatric condition or cognitive impairment that would hamper participation in interview/completion of self-reported questionnaires.

- Patients who are too ill (death is imminent), as determined by the referring health care professional, will be excluded.

- Patients with a Gastrointestinal Stroma Tumour (GIST) diagnosis, as they are quite unique in terms of type of disease and treatment.

- Patients with Kaposi sarcoma, as this disease occurs quite often in people with AIDS

- Patients with Carcinosarcoma as this disease is generally seen as a carcinoma

Studien-Rationale

Primary outcome:

1. a framework for a HRQoL measure for patients with sarcoma (Time Frame - 1 week (and for several issues 4 weeks according to EORTC questionnaire guidelines)):
the framework will outline which strategy to adopt for HRQoL in patients with sarcoma: the EORTC Quality of Life Questionnaire (QLQ)-C30 + one sarcoma module; EORTC QLQ-C30 + one sarcoma module + an item list; EORTC QLQ-C30 + item list. This will be based on analysis of the interview data (patients and HCPs) and the relevance of certain HRQoL rated by patients and health care professionals and possible identification of certain subgroups (according to tumour localization, type of sarcoma, disease stage and treatment).



Secondary outcome:

1. an exhaustive list of all HRQoL issues relevant to sarcoma patients (Time Frame - 1 week (and for several issues 4 weeks according to EORTC questionnaire guidelines)):
based on a literature review, analysis of interviews with patients and health care professionals we will create an exhaustive list of all HRQoL issues relevant to sarcoma patients.

2. the coverage of issues/items already available in the EORTC Item Library (Time Frame - 1 week (and for several issues 4 weeks according to EORTC questionnaire guidelines)):
the interview data and rating of HRQoL issues will be used to determine the overage of issues/ items in the EORTC Item Library and how the Item Library can be optimally used for the HRQoL measure for patients with sarcoma.

3. the proportion of patients in subgroups rating issues/items as relevant (Time Frame - 1 week (and for several issues 4 weeks according to EORTC questionnaire guidelines)):
In order to determine if issues are sarcoma-generic or dependent of sarcoma localization, sarcoma subtype, disease stage or treatment we will analyze the proportion of patients in each subgroup rating HRQoL issues or items as relevant

Studien-Arme

  • Patients
    Patients who have been or are being treated for sarcoma.
  • Health care professionals
    Health care professionals with extensive experience in sarcoma care (medical oncologists, radiation oncologists, surgical oncologists, orthopaedic surgeons, nurse specialists, psychologists, physiotherapists)

Quelle: ClinicalTrials.gov


Das könnte Sie auch interessieren
Junge Menschen vor Gebärmutterhalskrebs und anderen Krebsarten schützen
Junge+Menschen+vor+Geb%C3%A4rmutterhalskrebs+und+anderen+Krebsarten+sch%C3%BCtzen
© Jochen Schönfeld / Fotolia.com

Die Ständige Impfkommission (STIKO) hat die Impfempfehlungen zur HPV-Impfung erweitert. Während es die offizielle Empfehlung für Mädchen bereits seit dem Jahr 2007 gibt, empfiehlt sie die HPV-Impfung seit diesem Jahr auch für Jungen. Um auf die Wichtigkeit der HPV-Impfung hinzuweisen, hat die Bundeszentrale für gesundheitliche Aufklärung (BZgA) Informationsmaterialien entwickelt, die derzeit an die ärztlichen Praxen versendet werden und darüber...

Geballtes Wissen zu Krebs für alle
Geballtes+Wissen+zu+Krebs+f%C3%BCr+alle
© Krebsinformationsdienst, DKFZ; Bild: Pixabay 849820

Der offizielle Startschuss fiel am 30. März 1999. Die Internetseite des Krebsinformationsdienstes (KID), einer Abteilung des Deutschen Krebsforschungszentrums, ging online. Heute nutzen monatlich rund 600.000 Besucher die Seite. Gefragte Themen sind Hintergründe zur Erkennung und Behandlung von Krebs, neue Therapieverfahren, aber auch Tipps zum Umgang mit der Erkrankung im Alltag. Alle, die sich vor Krebs schützen möchten, finden ausführliche Informationen über...

Künstlerische Therapien in der Krebsbehandlung
K%C3%BCnstlerische+Therapien+in+der+Krebsbehandlung
© ChenPG / Fotolia.com

Viele Krebspatienten schöpfen durch Musik, Malen oder andere künstlerische Tätigkeiten neue Kraft. Doch lange Zeit reichte der wissenschaftliche Kenntnisstand nicht aus, um die Wirkung von Musik- oder Kunsttherapien zu belegen. Erst in den letzten Jahren wurden hierzu vermehrt psychoonkologische Studien durchgeführt, in denen es gelang, die Steigerung des Wohlbefindens von Patienten durch künstlerische Betätigungen nachzuweisen.